Included below are three videos of conversations with my father, Heero Hacquebord, who is a world expert in quality improvement, systems thinking, and statistical control in business. We will be discussing the overall quality in hospitals and how to improve a hospital’s quality. He was a long-term mentee of the late Dr. W. Edwards Deming. I respect him immensely and have much to learn from him still.
From inspiring patients to thorough research, our blog is for doctors seeking answers and information.
Since its introduction in the United States in the mid-2010s, Descemet stripping only (DSO) has revolutionized the surgical management of Fuchs dystrophy. Although similar procedures were originally explored in the 1950s and for some time after, these met with little success.
The current technique—pioneered in the United States by Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor of Ophthalmology and chair of the Department of Ophthalmology at NYU Grossman School of Medicine—involves removal of the diseased endothelium and mound-shaped aggregates, known as guttae, without the need for a donor graft.
From early on in his career, Jacques Hacquebord, MD, performed major reconstructive work on patients at NYC Health +
Hospitals/Bellevue, including many with hand and arm amputations. Caring for these patients introduced him to the fascinating
world of prosthetic devices. Working with occupational therapists, mental health experts, and those who make and fit artificial
limbs, known as prosthetists, he saw a field brimming with potential.
How many times have we, as therapists, prosthetists, and rehabilitation nurses, encountered a traumatic hand injury where the heroic efforts of a skilled microvascular hand surgeon saved the hand? Yet what does it mean to “save” a hand following many months of reconstructive procedures that may include replantation, deepening a web space, a free flap, pedicle flap, debulking, or toe-to-hand transfer?